Tweetorial on carcinoid tumor of the lung. I’ll add to it little by little every week 😊
#pathology #pulmpath
1/ Carcinoid tumor is the lower grade end of the spectrum of neuroendocrine tumors in the lung.
Caution: lung terminology is different from GI tract terminology
2/
In the lung, the terminology is
✴️ Typical carcinoid tumor
✴️ Atypical carcinoid tumor
✴️ Small cell carcinoma
✴️ Large cell neuroendocrine carcinoma
We don’t terms such as “well differentiated NET” because...this is #pulmpath and we are special 😜
3/
Carcinoid tumors are very similar on H&E to low grade NE tumors in the GI tract or pancreas. Nesting, odd patterns, bland cytology, granular chromatin (“salt and pepper”)
4/ ✴️ Most carcinoid tumors in the lung are typical carcinoids
✳️ you can’t tell typical from atypical carcinoids on cytology or in small biopsies
✴️ In these specimens, calling them “carcinoid tumor” is fine
✳️ In resections, you can tell typical from atypical
5/ Criteria for typical vs. atypical carcinoid tumor:
✴️ Mitoses (2/10 HPF is the cutoff)
✳️ Necrosis (none in typical, “punctate” in atypical)
✴️ Either one of these is sufficient for the label of atypical carcinoid
Do NOT differentiate these based on atypia or mets
6/ Grossly, carcinoid tumors often look a bit yellow and tend to be located within a bronchus or adjacent to a bronchus. Post-obstructive mucus plugs are common.
However, carcinoid tumors can also occur in the periphery of the lung.
8/
Atypical carcinoid tumors are more aggressive clinically than typical carcinoids. Both can metastasize to hilar/mediastinal nodes (even rarely to distant sites) but this is more common with atypical carcinoids. So this is why we count mitoses...
9/ What do typical and atypical carcinoids have in common?
✳️ Low grade cytology
✴️ Absence of extensive necrosis
✳️ Almost always positive for synaptophysin and chromogranin
✴️ Less than 10 mitoses per high power fields (usually far less!)
✳️ Treated surgically
10/ What is the #ihcpath profile of a typical carcinoid tumor?
Synaptophysin +
Chromogranin +
CD56 +
Cytokeratin + (try CAM5.2 if AE1/AE3 is neg)
TTF-1 weakly + or neg
p40 neg
Do you need to do #ihcpath in every case? No, but I get synaptophysin and chromogranin in most 😅
11/ What else can look like typical carcinoid tumor in the lung?
12/ Another tumor that many worry about but shouldn’t: paraganglioma
✅ Yes, they can look like carcinoid tumors
✅ But primary paraganglioma of the lung is vanishingly rare. Carcinoid is common. When your hear hoofbeats, think 🐎not 🦓
✅ if in doubt, get a pankeratin
13/ Back to atypical carcinoids. Since punctuate necrosis is such a key criterion, you should know what it looks like. It can be very focal and easy to miss. It usually contains necrotic nuclei, kind of like a florid form of apoptosis
@chriszioga @pathnoob
14/ What is the prognostic difference between typical and atypical carcinoid tumors? Per WHO:
5y survival 90% for typical carcinoid tumor, 60% for atypical carcinoid tumor
Remember: both can metastasize to nodes, although more with atypical
Data from our center are similar:
15/ Here’s an example of a lymph node metastasis from an atypical carcinoid tumor. Nodal involvement is a significant adverse prognostic factor.
References: PMID 14698535 and 11296182
@virenkaul @leticiakawano
Sorry for typo: “punctate”
16/ Now let’s address baby carcinoids also known as “carcinoid tumorlets”. Defined by an arbitrary size cutoff of 5mm, these are identical to carcinoid tumors except they are very tiny and completely benign
They are invariably located in the walls of bronchioles.
17/ As expected, carcinoid tumorlets are positive for synaptophysin, chromogranin and the nuclear neuroendocrine marker INSM1 (we were the first to report this).
The nuclei look neuroendocrine. No mitoses. No necrosis.
They are often seen in context of small airway disease
18/ Carcinoid tumorlets are commonly confused with meningothelial-like nodules. The latter are NOT neuroendocrine but instead resemble meningeal cells. They are positive for EMA, PR, vimentin (🙄) and CD56. We were the first to report CD56 in these lesions, a pitfall
19/ More about meningothelial-like nodules here. Remember: NOT tumorlets & NOT neuroendocrine
Follow the thread to learn about DIPNECH, a very controversial entity. It stands for “diffuse idiopathic pulmonary neuroendocrine cell hyperplasia”
20/ Most would agree that the term DIPNECH is appropriate if:
✅ innumerable tiny bilateral lung nodules
+
✅ pathology: numerous tumorlets and neuroendocrine “hyperplasia” undermining bronchiolar epithelium
+
✅ no inflammation or scarring
+
✅ obstructive PFTs
21/ There is no agreement on what to call lesions that don’t meet all the criteria in previous tweet. For example, multiple carcinoid tumorlets commonly occur in the background lung of carcinoid tumors. No obstructive PFTs. Is this DIPNECH? There is no agreement among experts
22/ Here’s what DIPNECH looks like. Tiny neuroendocrine nodules all over the place. The #ihcpath is synaptophysin. I like the strict definition that includes no inflammation and obstructive PFTs. Anything less and I describe.
23/
Both carcinoid tumorlets and meningothelial-like nodules can be mistaken for granulomas. Especially by first year residents 😉 . You can always blame anything on a PGY1 😂
See pics for comparison at identical magnification
24/ Now, some pics from the slide collection donated by @yro854 to this carcinoid #tweetorial
Chest radiograph, round shadow = carcinoid tumor. On a copy of the original, I’ve circled the areas I think show the lesion. Am I right @leticiakawano ?
#yalerosenslidecollection
25/ This lovely gross pic by @yro854 shows post-obstructive bronchiectasis caused by a carcinoid tumor #pathtweetorial #grosspath
On a copy of the original, I’ve circled the areas I think show the tumor. Am I right @yro854 ?
#yalerosenslidecollection
26/ For a recent update on metastatic lung carcinoids see this #pathtweetorial 👇🏾
Overlap is common because these abnormalities commonly occur together.
3.
Every week I will add my thoughts to this #pathtweetorial . I feel strongly about this topic because I see SO much smoking-related lung pathology that is misinterpreted and underrecognized. Not just SRIF (👇🏾) but also pigmented macrophages, commonly dismissed as “anthracotic”
1/4 (4-tweet thread)
A recent study in @ModernPathology
by Xie et el examined the ability of a deep convolutional neural network to diagnose which tumor in pleural effusions? #pathpolls
3/4
The authors claim the sensitivity and specificity of the deep convolutional neural network was somewhere between senior and junior cytopathologists. What were the numbers (sensitivity, specificity)?
cc: @DrNetto
1/ Announcing a contest to win a free pathology textbook!
Thanks to a brilliant idea by @DrMissWV and a generous offer by @science_press and @LizMontgomeryMD we are giving away a few free textbooks in an educational tweet contest called #pathbracket . See thread 👇🏾
2/
If you want to enter the contest, create a NEW educational pathology tweet between today and March 15 and tag it with #pathbracket
You must tag your own tweet. The tweet must have educational value. Tweetorials are allowed too. Contest is open to all.
3/ On March 16, #PathTweetAward judges led by @DrGeeONE will donate their time to pick 32 of the best tweets to enter in a bracket similar to #MarchMadness . Credit with the idea of a bracket goes to @DrMissWV
Progression through the bracket will be on the basis of polls.
1. How do we tell primary lung cancer from metastatic cancers from other sites?
It’s correct to say we should use all available clinical, radiologic and pathologic information, but that’s too vague to be helpful in a practical sense.
2. This #pathtweetorial is applicable mainly to #pulmpath . The principles in each organ are different. A carcinoma in a lymph node is a metastasis by definition. Not so in lung or colon.
IMHO it’s a mistake to approach a carcinoma in the lung as carcinoma of unknown primary
3. Most metastatic carcinomas to the lung occur after the primary carcinoma has already been diagnosed in another site.
💥Clinicians: give your pathologists this information! If you don’t, this is substandard, dangerous patient care.